Hamilton and BioFluidica Pen Next Generation Liquid Biopsy Platform Co-Marketing Agreement

BioFluidica LiquidScan™ Harnesses the Power of Microfluidics SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide. Biofluidica has developed the…

Click here to view original post